Last reviewed · How we verify
NCT05037318: BPSM
Breaking Bad News - Optimizing Stress Response and Communication Performance in Medical Students
NA trial testing Stress arousal reappraisal in Stress Reaction in 229 participants. Completed in 29 February 2024.
29 February 2024
Quick facts
| Lead sponsor | University of Bern |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 229 |
| Start date | 21 April 2022 |
| Primary completion | 29 February 2024 |
| Estimated completion | 29 February 2024 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Stress arousal reappraisal
- Worked examples
Conditions studied
- Stress Reaction — all drugs for Stress Reaction →
Sponsor
University of Bern
Who can join
18 and older, any sex, with Stress Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Breaking bad news (e.g., telling patients that they have cancer) is not only very stressful for the patients concerned, but also for the physicians delivering the diagnosis. It is unclear how this burden and the associated communication performance can be optimized. The project contributes to this goal. The main goal of the project is to scientifically analyze to what extent the stress reaction and communication performance of medical students can be optimized when breaking bad news. Two strategies will be employed and tested for their effectiveness: First, "stress arousal reappraisal", which consists in reinterpreting physiological arousal (e.g., increased heart rate) as adaptive and beneficial for task performance. Second, medical students can be well prepared for breaking bad news by learning from worked examples (step-by-step demonstrations of how to break bad news). The investigators hypothesize that both strategies will shift the interpretation of breaking bad news from a threat to a challenge state. This will lead to better communication performance during the task. To test the hypothesis, about 200 medical students' communication performance, cardiovascular activity, stress hormone release, and subjective stress perception when communicating a serious cancer diagnosis to a simulated patient (actor) will be measured. The results of the study provide a first comprehensive picture of the psychophysiological stress patterns of medical students who are entrusted with a stressful communication task. Ultimately, this may promote stress management and communication skills in future physicians.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
From threat to challenge-Improving medical students' stress response and communication skills performance through the combination of stress arousal reappraisal and preparatory worked example-based learning when breaking bad news to simulated patients: study protocol for a randomi
Bosshard M, Schmitz FM, Guttormsen S, Nater UM, et al · · 2023 · cited 9× · PMID 37165406 · DOI 10.1186/s40359-023-01167-6 -
Improving breaking bad news communication skills through stress arousal reappraisal and worked examples.
Bosshard M, Guttormsen S, Nater UM, Schmitz F, et al · · 2025 · cited 5× · PMID 40074561 · DOI 10.1111/medu.15658 -
A randomized controlled trial evaluating stress arousal reappraisal and worked example effects on psychophysiological responses during breaking bad news.
Bosshard M, Guttormsen S, Nater UM, Schmitz F, et al · · 2025 · cited 1× · PMID 40604103 · DOI 10.1038/s41598-025-06995-7 -
Optimizing stress in breaking bad news: a randomized controlled trial on the psychophysiological effects of stress arousal reappraisal and worked-example interventions among medical students
Bosshard M, Guttormsen S, Nater UM, Schmitz F, et al · · 2025 · DOI 10.1101/2025.01.21.25320844
Verify or expand the search:
- PubMed search for NCT05037318
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stress Reaction
Currently open trials in the same condition.
- NCT06037785 — Self-Management Interventions After an ICD Shock · NA · recruiting
- NCT06105853 — Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder · NA · recruiting
- NCT05685368 — Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease · Phase 1, PHASE2 · recruiting
- NCT06056375 — Biological and Behavioral Outcomes of Community Nature Walks · Phase 1 · recruiting
- NCT06269614 — Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition · NA · active not recruiting
Other University of Bern trials
Trials by the same sponsor.
- NCT05940662 — Cost Effectiveness of Various Implant Placement Protocols in the Esthetic Zone · Phase 4 · suspended
- NCT02919163 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 6 of 7) · NA · not yet recruiting
- NCT02919189 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 5 of 7) · NA · not yet recruiting
- NCT04817592 — Characterization of the Corneal Biomechanics of Patients Treated by Corneal Lenticule Extraction for Advanced Refractive · not yet recruiting
- NCT06806150 — The INSPIRE Study: INvestigation of Swiss Physicians Inner-life, Resilience, and Emotions · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05037318 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Bern
- Last refreshed: 5 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05037318.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing